(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Anticuerpos monoclonales > DA - CIMA - Terapia génica y Hepatología - Anticuerpos monoclonales - Artículos de Revista >

Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma
Autor(es) : Hu, J. (Jie)
Dong, A. (Aiwen)
Fernandez-Ruiz, V. (Verónica)
Shan, J. (Juanjuan)
Kawa, M. (Milosz)
Martinez-Anso, E. (Eduardo)
Prieto, J. (Jesús)
Qian, C. (Cheng)
Palabras clave : Carcinoma, Hepatocellular/genetics
Gene Expression Regulation, Neoplastic
Liver Neoplasms, Experimental/genetics
Neovascularization, Pathologic/genetics
Wnt Proteins/antagonists & inhibitors
Fecha incorporación: 2009
Editorial : American association for cancer research
Versión del editor: http://dx.doi.org/10.1158/0008-5472.CAN-09-0541
ISSN: 0008-5472
Cita: Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martinez-Anso, et al. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res 2009 Sep 1;69(17):6951-6959.
Resumen
Aberrant activation of Wnt signaling plays an important role in hepatocarcinogenesis. In addition to direct effects on tumor cells, Wnt signaling might be involved in the organization of tumor microenvironment. In this study, we have explored whether Wnt signaling blockade by exogenous expression of Wnt antagonists could inhibit tumor angiogenesis and control tumor growth. Human Wnt inhibitory factor 1 (WIF1) and secreted frizzled-related protein 1 (sFRP1) were each fused with Fc fragment of human IgG1 to construct fusion proteins WIF1-Fc and sFRP1-Fc. The recombinant adenoviral vectors carrying WIF1-Fc and sFRP1-Fc driven by cytomegalovirus promoter were constructed. Ad-WIF1-Fc or Ad-sFRP1-Fc induced the expression and correct conformation of WIF1-Fc and sFRP1-Fc fusion proteins. These molecules caused down-regulation of E2F1, cyclin D1, and c-myc and promoted cell apoptosis in hepatocellular carcinoma cells. Treatment of established hepatocellular carcinoma tumors with Ad-WIF1-Fc and/or Ad-sFRP1-Fc resulted in significant inhibition of tumor growth and prolonged animal survival. The antineoplastic effect was associated with increased apoptosis of tumor cells, reduced microvessel density, and decreased expression of vascular endothelial growth factor and stromal cell-derived factor-1. Tube formation and migration of human microvascular endothelial cells and mouse endothelial progenitor cells (EPC) were significantly inhibited by both WIF1-Fc and sFRP1-Fc. In addition, these molecules blocked EPC differentiation and caused EPC apoptosis. Our data indicate that Wnt antagonists WIF1-Fc and sFRP1-Fc inhibit Wnt signaling and exert potent antitumor activity by increasing the apoptosis rate in tumor cells and by impairing tumor vascularization.
Enlace permanente: http://hdl.handle.net/10171/20302
Aparece en las colecciones: DA - CIMA - Terapia génica y Hepatología - Anticuerpos monoclonales - Artículos de Revista

Ficheros en este registro:

No hay ficheros asociados a este ítem.

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.